• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 08/20/14

    • 30-Day SEC Yield1

      -0.11%
    • Total Net Assets

      $520.3M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/19/2014
  • Portfolio Composition (%)
    as of 08/20/14

    • % of Net Assets
    • Stocks

      99.84
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.16
  • Download All HoldingsAll Holdings (%)as of 08/20/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    841,591
    84,823,95716.30
    Amgen Inc
    AMGN US
    457,574
    60,710,91811.67
    Celgene Corp
    CELG US
    574,411
    52,845,81210.16
    Biogen Idec Inc
    BIIB US
    145,284
    49,771,3939.57
    Vertex Pharmaceuticals Inc
    VRTX US
    287,076
    26,210,0395.04
    Alexion Pharmaceuticals Inc
    ALXN US
    141,107
    23,810,3954.58
    Regeneron Pharmaceuticals Inc
    REGN US
    68,550
    23,668,9444.55
    Illumina Inc
    ILMN US
    119,879
    20,734,2723.99
    Biomarin Pharmaceutical Inc
    BMRN US
    261,731
    18,493,9123.55
    Pharmacyclics Inc
    PCYC US
    152,692
    18,384,1173.53
    Qiagen Nv
    QGEN US
    760,711
    18,287,4923.52
    Incyte Corp Ltd
    INCY US
    329,561
    17,025,1213.27
    Medivation Inc
    MDVN US
    182,123
    15,784,6003.03
    Alkermes Plc
    ALKS US
    244,243
    10,776,0012.07
    Cubist Pharmaceuticals Inc
    CBST US
    158,442
    10,267,0421.97
    Intercept Pharmaceuticals Inc
    ICPT US
    35,637
    10,124,1151.95
    Covance Inc
    CVD US
    116,841
    9,944,3381.91
    United Therapeutics Corp
    UTHR US
    105,888
    9,876,1741.90
    Isis Pharmaceuticals Inc
    ISIS US
    210,882
    7,439,9171.43
    Charles River Laboratories Internationa
    CRL US
    120,114
    7,143,1801.37
    Nps Pharmaceuticals Inc
    NPSP US
    223,708
    6,163,1551.18
    Cepheid Inc
    CPHD US
    125,054
    4,839,5900.93
    Myriad Genetics Inc
    MYGN US
    123,880
    4,646,7390.89
    Seattle Genetics Inc
    SGEN US
    106,186
    4,564,9360.88
    Ariad Pharmaceuticals Inc
    ARIA US
    508,996
    3,084,5160.59
    Other/Cash
    845,3360.16
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.